With an aim to control the onset of various monogenic disorders such as the metabolic disorders, endocrine disorders, hemoglobin disorders and others, the Department of Biotechnology (DBT) will soon begin research on monogenic disorders.
Read more @http://www.pharmabiz.com/NewsDetails.aspx?aid=101466&sid=1